Prevalence of preoperative anaemia in patients having first-time cardiac surgery and its impact on clinical outcome. A retrospective observational study

Perfusion (United Kingdom)

Volumn 30, Issue 4, 2015, Pages 277-283

  Kim, C J ^a   Connell, H ^a   McGeorge, A D ^a   Hu, R ^a  

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

anaemia; cardiac surgery; clinical outcome; morbidity; mortality; transfusion rate

Indexed keywords

BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; CREATININE; FRESH FROZEN PLASMA;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HEMODIALYSIS; HEMOFILTRATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS;

AGED; ANEMIA; BLOOD COMPONENT TRANSFUSION; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84930729770     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659114542457     Document Type: Article

References (25)

1. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.. 2011 ;:
2. Karkouti K, Wijeysyndera D, Beattie W. Risk associated with preoperative anemia in cardiac surgery. A multicenter Cohort Study. Circulation. 2008 ; 117: 478-484
3. Hung M, Besser M, Sharples S, Nair, Klein A. The prevalence and association with transfusion, intensive care unit stay and mortality of preoperative anaemia in a cohort of cardiac surgery patients. Anaesthesia. 2011 ; 66: 812-818
4. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thoracic Surg. 2007 ; 83 ( S27-86 ):
5. Stephen D, Surgenor E. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesthesia and Analgesia. 2009 ; 108: 1741-1746
6. Murphy G, Angelini G. Indications for blood transfusion in cardiac surgery. Ann Thoracic Surg. 2006 ; 82: 2323-2334
7. Kulier A, Levin R, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007 ; 117: 471-479
8. Khanna M, Herbert P, Fergusson D. Review of the clinical practice literature on patient characteristics associated with perioperative allogenic red blood cell transfusion. Transfus Med Rev. 2003 ; 17: 110-119
9. Koch C, Wend Y, Zhou S, et al. Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass sugery. J Cardiothorac Vasc Anesth. 2003 ; 17: 585-593
10. Claridge J, Sawyer R, Schulman A, et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 2002 ; 68: 566-572
11. Toy P, Lowell C. TRALI: definition, mechanisms, incidence and clinical relevance. Best Pract Res. 2007 ; 21: 183-192
12. Reeves B, Murphy G. Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Curr Opin Anaesthesiol. 2008 ; 21: 669-673
13. Karski J, Mathieu M, Cheng D, Carroll J, Scott G. Etiology of preoperative anemia in patients undergoing scheduled cardiac surgery. Can J Anaesth. 1999 ; 46: 979-982
14. Garcia-Erce J, Cuenca J, Munoz M. Role of intravenous iron in elective and non-elective orthopedic surgery. Semin Hematol. 2006 ; 43: S32-35
15. Beris P, Munnoz M, Garcia-Erce J, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008 ; 10: 599-604
16. Georgopoulos D, Matamis D, Routsi C, et al. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study. Crit Care. 2005 ; 9: R508-515
17. Fisher J. Pharmacologic modulation of erythropoietin production. Ann Rev Pharmacol Toxicol. 1988 ; 28: 101-122
18. Weltert L, D'Alessandro S, Nardella S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg. 2010 ; 139: 621-627
19. Yoo Y, Shim J, Kim J, Jo Y, Lee J, Kwak Y. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011 ; 11: 929-937
20. Alghami AA, Albanna MJ, Guru V, Brister SJ.. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg. 2006 ; 21: 320-326
21. Cladella M, Farré N, Cómin-Colet J, et al. Effects of preoperative intravenous erythropoietin plus iron on outome in anemic patients after cardiac valve replacement. Am J Cardiol. 2012 ; 110: 1021-1026
22. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet. 1993 ; 341: 1227-1232
23. D'Ambra M, Gray RJ, Hillman R, et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg. 1997 ; 64: 1686-1693
24. Cómin-Colet J, Ruiz S, Cladella M, Rizzo M, Torres A, Bruguera J. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. J Card Fail. 2009 ; 15: 727-735
25. Van der Meer P, Groenveld H, Januzzi JJ, Van Veldhuisen D. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart. 2009 ; 95: 1309-1314